Chronic Insomnia: clinical trials and information
Chronic Insomnia clinical trials in Canada
| Phase | Provinces | ||||
|---|---|---|---|---|---|
| Lemborexant vs Zopiclone vs Clonidine for Insomnia Treatment in Chronic Pain Patients NCT05618002 | Recruiting | British Columbia | Salem Anaesthesia Pain Clinic | 2022-11-08 |
Chronic Insomnia clinical trials worldwide (outside Canada)
11 trials, 3 recruiting or not yet recruiting. Recruiting first.
About Chronic Insomnia
What is Chronic Insomnia?
"Chronic Insomnia" is the term study registrants used on ClinicalTrials.gov. Registry labels are not always standard medical terms, and close variants of the same label appear as separate entries. In this snapshot the term appears on 12 chronic pain registry records worldwide.
How is Chronic Insomnia usually assessed?
Assessment of chronic pain generally involves a clinician taking a detailed history, a physical examination and, where relevant, tests to look for underlying causes. Pain rating scales and questionnaires about function, sleep and mood are often used. The approach depends on the person and the condition.
What kinds of treatments are studied for Chronic Insomnia?
Registered studies cover medicines, medical devices (such as nerve stimulators), procedures (such as nerve blocks or injections), physical and movement therapies, psychological approaches (such as cognitive behavioural therapy), education programs and digital tools. Being studied in a trial does not mean a treatment works or is approved. The interventions listed on this page come directly from the registry records.
How can I find Chronic Insomnia clinical trials in Canada?
This page lists 1 registry record for this term with at least one site in Canada, recruiting studies first. Each trial page links to the official ClinicalTrials.gov record, which lists the study contacts. Recruiting status changes often, so check the registry, and talk to your doctor before joining a study.
Related conditions
Related interventions
Related US FDA drug labels
Labels whose indications text mentions this term. US labels, not Health Canada Product Monographs.
- Duloxetine delayed-release capsules, USP
- Cymbalta
- Duloxetine delayed-release capsules
- Duloxetine delayed-release capsules, USP
- Cymbalta
- Duloxetine delayed-release capsules USP
- Duloxetine delayed-release capsules
- Duloxetine delayed-release capsules, USP
- Cymbalta
- Duloxetine delayed-release capsules, USP
- Duloxetine delayed-release capsule
- Cymbalta
Source: ClinicalTrials.gov (US National Library of Medicine), snapshot October 2026. Check the registry for current recruiting status.